|
Almeida Capital is pleased to be a premier sponsor of AltAssets
|
FREE newsletter RSS
INTELLIGENCE
RECRUITMENT
KNOWLEDGE BANK
EVENTS
SECTOR ANALYSIS
HEDGE FUNDS
|
PRINT THIS PAGE Bridgepoint acquires majority of capsules contract manufacturer Swiss Caps07/09/2005. Source: AltAssets. 
 Bridgepoint has acquired a majority stake in Swiss Caps, a contract manufacturer of capsules and tablets for the health, nutritional supplements and pharma industries.
Financial details of the transaction have not been disclosed.
The Swiss-based company develops, manufactures and packages capsules and tablets for third parties, and also owns rights on 60 herbal over-the-counter pharmaceuticals. Swiss Caps has five production facilities in Switzerland, Germany, Romania and in the US. In 2004 Swiss Caps had net sales of €142m.
Dr Tony Bunker, director of Bridgepoint in Frankfurt, said 'Under the leadership of Peter Greither and his team, Swiss Caps has grown steadily to become a highly regarded operator in its sector. We believe that it is now capable of further growth, particularly in the development of high growth, high margin registered drugs and through the optimisation of its manufacturing processes.'
Bridgepoint focuses on investments in mid-market companies. The firm's other recent investments in the healthcare sector include Attendo, a private operator of elderly care homes and services in the Nordic region; and Tunstall, a specialist in telecare systems/products for the elderly and infirm.
Copyright © 2005 AltAssets
|
 
|
|
|
